Infection and Immunity, September 1998, p. 4100-4107, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Research Institute,
Received 20 April 1998/Returned for modification 22 May
1998/Accepted 2 June 1998
Shiga toxins 1 (Stx1) and 2 (Stx2) are encoded by toxin-converting
bacteriophages of Stx-producing Escherichia coli (STEC), and so far two Stx1- and one Stx2-converting phages have been isolated
from two STEC strains (A. D. O'Brien, J. W. Newlands, S. F. Miller, R. K. Holmes, H. W. Smith, and S. B. Formal, Science 226:694-696, 1984). In this study, we isolated two
Stx2-converting phages, designated Stx2 Shiga toxin-producing
Escherichia coli (STEC) strains are associated with
diarrhea, hemorrhagic colitis, and the hemolytic-uremic syndrome (HUS)
in humans. Serotype O157:H7 constitutes the main STEC causative
serotype, but other serotypes such as O26:H11 are also involved
(24). The frequency with which STEC infections are being
reported continues to increase, probably reflecting both a greater
interest in this pathogen and a real increase in its incidence and
geographic spread (10). In Japan, an epidemic STEC O157:H7
infection started with a large outbreak in primary schools in Okayama
in 1996, which involved 468 patients, 2 of whom developed HUS and died
(52). This was followed by a large outbreak of STEC O157:H7
infection in primary schools in Osaka in 1996, affecting more than
6,000 children (52).
STEC isolated from patients with hemorrhagic colitis produces two
immunologically distinct toxins that are cytotoxic to Vero cells
(47, 49). One of the two Vero toxins is physicochemically, biologically, and immunologically identical to Shiga toxin
from Shigella dysenteriae type 1 (32) and is
known as Shiga toxin 1 (Stx1), while the other is immunologically
unrelated to Shiga toxin (49, 58) and is known as Shiga
toxin 2 (Stx2). Both Stx1 and Stx2 have been purified and their
physicochemical and biological properties have been reported (32,
58). It has been proposed that the E. coli
O157:H Several investigators have reported that production of Stx1 and Stx2 in
E. coli is conferred by toxin-converting bacteriophages (33, 47-49). The Stx1 encoded on the phages was first
demonstrated in E. coli O26:H11 strain H19 (47,
48). Strain H19 was lysogenized by two Stx-converting phages,
designated H19A and H19B, which possess different host
ranges. Phage H19B is related to coliphage lambda and carries the
stx1 operon far from the attachment site, indicating
that it became bacteriophage associated in the distant past
(19). O'Brien et al. reported that another STEC O157:H7 strain, 933, was lysogenized with two Stx-converting phages,
designated 933J and 933W; phage 933J was indistinguishable from the
Stx-converting phage H19A of E. coli H19 (33).
They also reported that E. coli 933 makes both Stx1 and Stx2
and that Stx1 is encoded by phage 933J while Stx2 is encoded by phage
933W (49). Subsequently, we also reported that STEC
O157:H7 strain 83-1386 or J-2 was lysogenized with Stx1- or
Stx2-converting phage and that the phages were similar to those of H19B
and 933W, respectively (23, 59). In summary, two
Stx1-converting phages, represented by H19B and 933J, and one
Stx2-converting phage, represented by 933W, have been reported in the
literature to date (35).
Interestingly, it has been reported that none of the Stx-producing
S. dysenteriae type I strains or Stx2 variant-producing E. coli strains possess the toxin-converting phages. In
fact, DNA hybridization analysis with probes specific for
toxin-converting phage DNA revealed that several STEC and edema
disease-causing strains, but not Shigella strains,
possessed H19A- or 933W-related phage sequences, although the mechanism
of infection of the Stx-converting phages in E. coli strains
remains obscure (31). Therefore, these studies led us
to investigate whether the production of Stx1 or Stx2 from
STEC strains isolated from the outbreaks in Japan are associated with
Stx-converting phages.
In this study, we isolated two distinct Stx2-converting phages,
designated Stx2 Bacterial strains, growth media, and plasmid construction.
The bacterial strains and plasmids used in this study are listed in
Table 1. The growth media used were
Luria-Bertani (LB) broth prepared with half the usual amount of NaCl
and supplemented with 2.5 mM CaCl2. When necessary,
ampicillin, kanamycin, tetracycline, or chloramphenicol was added at
100, 30, 50, or 50 µg/ml, respectively. pMAW302 and pMAW320 were
constructed by ligating an 1,800-bp EcoRI fragment
encompassing the nucleotides from position 303 upstream of the 5' end
of fadL to position 153 downstream from the 3' end (4), which was amplified by PCR with the primers
5'-GAATTCCGGAAAGTGCTGCTCCAGTTGTTAA-3' and
5'-GAATTCCTGTGGATACCGCTTATTGATTTGA-3'. Both primers
contained an EcoRI site. pMAW301 was constructed by ligating
a 1,600-bp EcoRI fragment encompassing the nucleotides from
position 100 upstream of the 5' end of lamB to position 160 downstream from the 3' end (5), which was amplified by PCR
with the primers 5'-GAATTCTCGACTGCATAAGGAGCCGGGCGTT-3'
and 5'-GAATTCTTCAGATAATGACAACCTGTTTTTTA-3'. Both
primers contained an EcoRI site.
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-I and Stx2
-II, from two
clinical strains of STEC associated with the outbreaks in Japan in 1996 and found that Stx2
-I resembled 933W, the previously reported
Stx2-converting phage, in its infective properties for E. coli K-12 strain C600 while Stx2
-II was distinct from them.
The sizes of the plaques of Stx2
-I and Stx2
-II in C600 were
different; the former was larger than the latter. The restriction maps
of Stx2
-I and Stx2
-II were not identical; rather, Stx2
-II DNA
was approximately 3 kb larger than Stx2
-I DNA. Furthermore,
Stx2
-I and Stx2
-II showed different phage immunity, with
Stx2
-I and 933W belonging to the same group. Infection of C600 by
Stx2
-I or 933W was affected by environmental osmolarity differently
from that by Stx2
-II. When C600 was grown under conditions of high
osmolarity, the infectivity of Stx2
-I and 933W was greatly decreased
compared with that of Stx2
-II. Examination of the plating efficiency
of the three phages for the defined mutations in C600 revealed that the
efficiency of Stx2
-I and 933W for the fadL mutant
decreased to less than 10
7 compared with that for C600
whereas the efficiency of Stx2
-II decreased to 0.1% of that for
C600. In contrast, while the plating efficiency of Stx2
-II for the
lamB mutant decreased to a low level (0.05% of that for
C600), the efficiencies of Stx2
-I and 933W were not changed.
This was confirmed by the phage neutralization experiments with
isolated outer membrane fractions from C600, fadL mutant,
or lamB mutant or the purified His6-tagged FadL
and LamB proteins. Based on the data, we concluded that FadL acts as
the receptor for Stx2
-I and Stx2
-II whereas LamB acts as the
receptor only for Stx2
-II.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
strain E32511 produces yet another distinct toxin
resembling the Stx2 family (14). Two variants of Stx2 have
been well characterized (9, 54). The variants, designated
SLT-IIv (Stx2e) and SLT-IIva, are cytotoxic for Vero and HeLa cells.
SLT-IIv (Stx2e) is the causative agent of edema disease in pigs
(25, 54), while SLT-IIva has been associated with diarrhea
in a human infant (21).
-I and Stx2
-II, from clinical strains
of STEC associated with the outbreak in Japan in 1996. Examination of
the phage plaque sizes, the restriction endonuclease maps, the
specificity of lysogenic immunity, the osmotic regulation of
infection, and the receptors indicated that Stx2
-I and Stx2
-II are different in their infective properties. The possibility of diverse host E. coli strains acquiring Stx2-converting
phages and its implications are discussed.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
TABLE 1.
Bacterial strains and plasmids used in this study
Genetic procedures. Transformation was performed as described by Dagert and Erlich (6). Generalized transduction with bacteriophage P1 was carried out as described by Miller (27).
Preparation of Stx2-converting phages from STEC strains. The method for the preparation of Stx2-converting phages from STEC strains has been described previously (23, 59). Each STEC strain was grown at 37°C for 2 h in LB broth supplemented with 2.5 mM CaCl2. The cells were harvested by centrifugation, suspended in saline, and irradiated with UV light. The irradiated bacteria were inoculated into the same medium and incubated at 37°C for 2 h. A few drops of chloroform was added to the culture, and the supernatant obtained by centrifugation was sterilized by being passed through a Millipore (Bedford, Mass.) filter membrane (pore size, 0.45 µm). The sterilized supernatant was mixed with a fresh culture of E. coli C600, added to LB soft agar, and poured onto an LB hard-agar plate. Lysogenized bacteria were isolated from each plaque formed on the plate, and the stx2 gene of each lysogenized strain was determined by colony hybridization with an stx2 gene probe (59).
Colony screening by stx gene probe
hybridization.
Lysogenized bacteria were cultured on nylon
membranes (GeneScreen hybridization transfer membranes [NEN Research
Products, Boston, Mass.]) placed over LB agar plates. The plates were
incubated at 37°C until bacterial colonies reached approximately 1 mm
in diameter. The bacterial colonies on the nylon membrane were lysed, the chromosomal DNA was denatured by published procedures
(8), and the nylon membranes were analyzed by Southern
hybridization with digoxigenin-labeled stx1 or
stx2 gene probes, which contained an intact stx1
or stx2 gene, respectively (23, 59). Southern hybridization was performed by following the instruction manual provided with the DNA labeling and detection kit (Boehringer, Mannheim,
Germany). Among the lysogenized strains screened, lysogenized E. coli C600(Stx2
-I) and C600(Stx2
-II), which were
isolated from Okayama O-27 and Morioka V526, respectively, were used to isolate Stx2
-I and Stx2
-II.
ELISA. A previously developed sensitive enzyme-linked immunosorbent assay (ELISA) (36) that can detect as little 50 pg of Stx2 per ml was used for the toxin assay. Filter-sterilized culture supernatants and bacterial lysates obtained by sonication were tested by the ELISA. Polystyrene beads coated with anti-Stx2 were used as the solid phase. Fab' of anti-Stx2 conjugated with horseradish peroxidase by the maleimide method (20) was used as the second antibody, and the substrate was tetramethylbenzidine.
Assay for cytotoxicity. Assay for cytotoxicity to Vero cells was performed as described previously (32). Briefly, Vero cells were grown in Eagle's minimal essential medium supplemented with 2% fetal calf serum, 0.4% glucose, 0.15% sodium bicarbonate, and 0.003% phenol red. Cytotoxicity was assayed in wells of a Falcon microtiter plate (Becton Dickinson, Franklin Lakes, N.J.). About 104 cells in 0.15 ml of growth medium were seeded into each well. Filter-sterilized culture supernatants and bacterial lysates obtained by sonication were tested for cytotoxicity. Test samples (0.02 ml) were added to each well and incubated under 5% CO2 in air at 37°C. The cells were observed microscopically for 7 days. The cytotoxic titers were determined by using 10-fold serial dilutions; the highest toxin dilution that caused lysis of 50% of the cell monolayer was taken as the titer of each toxin.
Restriction mapping and cloning. Restriction endonucleases were purchased from Takara Shuzo (Tokyo, Japan), and digestions were performed by following the instructions of the manufacturer. Phage lambda DNA digested with HindIII or a 1-kb DNA ladder (GIBCO BRL, Rockville, Md.) was used as a molecular weight standard. The phage DNA was digested with BamHI or XhoI. These digested fragments were ligated with BamHI or XhoI-digested pBluescript (Stratagene, La Jolla, Calif.) and were transformed into E. coli XLI-Blue. Finally, all digested fragments were cloned. Restriction mapping was performed by a variety of methods, including double digestion, digestion of isolated fragments, Southern hybridization, and partial sequencing.
DNA sequencing. Nucleotide sequencing was carried out by the chain termination technique of Sanger et al. (44) with the dye terminator kit (Applied Biosystems Inc., Norwalk, Conn.). The universal T3 and T7 primers and synthetic oligonucleotide primers were used for sequencing in a walking strategy. Oligonucleotide primers for sequencing were synthesized on an Oligo1000M DNA synthesizer (Beckman, Palo Alto, Calif.) and purified by reverse-phase high-pressure liquid chromatography (Waters, Milford, Mass.). The DNA sequence was obtained with an ABI 377 automated sequencer (Applied Biosystems Inc.).
Phage sensitivity testing and phage neutralization. Phage sensitivity was quantitated by placing the test culture, which was incubated with 10-fold-serially diluted portions of the phage, in an overlay on LB agar plates, and the plates were incubated at 37°C for 18 h. The PFU were calculated by counting the plaque numbers (41).
(i) Infection of Stx2-converting phage under high-osmolarity conditions. Strain C600 was cultured in LB broth samples supplemented with various concentrations of NaCl or sucrose, which were used as high-osmolarity media. The bacterial culture (5 × 107 cells) was incubated with 5 × 103 PFU of Stx2-converting phage in a volume of 0.2 ml. After incubation at 37°C for 60 min, the samples were plated to determine the infecting phage.
(ii) Stx2-converting phage neutralization by the outer membrane
fraction.
Outer membrane were prepared from 50 ml of cells grown
to an optical density at 600 nm of 1.0 in LB broth essentially by the method of Manning et al. (26). The insoluble fraction
obtained after extraction of whole-cell envelopes with 2% Triton X-100 and 5 mM MgCl2 was called the outer membrane fraction, and
it was suspended in distilled water and stored at
20°C. The outer membrane fraction (100 µg/ml) was incubated with 5 × 103 PFU of Stx2-converting phage in a volume of 1 ml. After
incubation at 37°C for 60 min, 0.2-ml samples were plated with strain
C600 to determine the plaque number of surviving phage.
(iii) Stx2-converting phage neutralization by His6-tagged FadL or LamB protein. A fusion protein purification was performed as described previously (53). A fusion protein of FadL and LamB tagged with six histidine residues at the N terminus was constructed by using the QIAexpress system with pQE-30 plasmid (Qiagen, Valencia, Calif.). The FadL-LamB fusion protein purified by Ni-nitrilotriacetic acid chromatography (Qiagen) was used for the Stx2-converting phage neutralization experiments described in Fig. 5. Purified fusion protein was incubated with 5 × 103 PFU of Stx2-converting phage in a volume of 1 ml. After incubation at 37°C for 60 min, 0.2-ml samples were plated with strain C600 to determine the plaque number of surviving phage.
| |
RESULTS |
|---|
|
|
|---|
Isolation of Stx2-converting phages from STEC strains.
Five
STEC O157:H7 strains associated with different outbreaks in Japan in
1996 (Table 1) were used to search for Stx2-converting phages. Each of
the representative strains used produced large amounts of Stx1 and Stx2
(data not shown). In a typical experiment, approximately 500 plaques
formed on a plate seeded with C600 by UV induction from a
STEC strain such as Morioka V526. To isolate Stx1- or
Stx2-converting phages, we excised some of the plaques, purified them
on LB agar plates, and examined them for the presence of
stx1 or stx2 genes by colony hybridization with
stx1 or stx2 gene probes (see Materials and
Methods). The yield of plaques that gave rise to stx1- and
stx2-positive clones obtained from Okayama O-27 or
Yokohama 97.4-C was 2 to 10%, and the yield of plaques
from Morioka V526 was 5 to 10%. Interestingly, the morphology of
the plaques which gave rise to the stx1-positive clones
was uniform, while those which gave the
stx2-positive clones included plaques with diameters of 1 and 3 mm (Fig. 1). We therefore
designated the two representative phages which hybridized with
the stx2 probe Stx2
-I (3-mm plaque) and Stx2
-II
(1-mm plaque), and these were derived from Okayama O-27 and
Morioka V526, respectively (Fig. 1).
|
Characterization of Stx2-converting phages.
To assess the Stx2
activity in Stx2
-I and Stx2
-II, levels of Stx2 protein
present in the whole bacterial lysates or culture supernatants of C600
lysogenized with Stx2
-I or Stx2
-II were investigated by
the polystyrene bead ELISA with anti-Stx2 antibody or by the
cytotoxicity assay using Vero cells. As shown in Table 2, similar amounts of Stx2 were expressed
from C600(Stx2
-I) and C600(Stx2
-II), although the level
of intracellular Stx2 production was half of the level in Okayama O-27
or Morioka V526 cells. Although some Stx2 was secreted from the two
C600 lysogens into the culture supernatants, the level of each was 1/10
of that secreted from the parental O157:H7 strains. This result was
also reproducible in the Vero cell cytotoxicity assay; however, the
levels of Stx2 secreted into the culture supernatants of
C600(Stx2
-I) and C600(Stx2
-II) were further reduced
compared with those of Okayama O-27 and Morioka V526 (Table 2). These
data suggest that Stx2
-I and Stx2
-II encode
Stx2-associated toxin and that in Okayama O-27 or Morioka V526, the
Stx2 protein can be secreted into the culture supernatants more
efficiently than in the respective lysogenized C600 strains.
|
Relationship of Stx2-converting phages to 933W.
To assess the
relationship between Stx2
-I or Stx2
-II and 933W, which is
the sole Stx2-converting phage known that has been isolated from
O157:H7 (933 strain) (33), we examined the three phages for
their lysogenic immunity. As shown in Table
3, Stx2
-I and Stx2
-II
showed no immunity to each other whereas Stx2
-I, but not
Stx2
-II, showed immunity to 933W, suggesting that Stx2
-I is closely related to 933W but not to Stx2
-II.
|
-I and Stx2
-II, we
constructed restriction maps of the phage DNA including the location of
the two stx2 genes as described in Materials and Methods. As shown in Fig. 2, although the restriction
maps are similar, the full length of Stx2
-II was 3 kb longer
than Stx2
-I, which resulted mostly from the differences of each
of the BamHI-XhoI fragments containing the
stx2 gene. In this study, we sequenced the two stx2 genes in Stx2
-I and Stx2
-II and found
that the two stx2 sequences were identical to each other and
that they were also identical to the stx2 gene from 933W
(11, 21, 22, 54). The open reading frames containing the
stx2 gene of Stx2
-I and Stx2
-II were located
downstream of p gene of phage
, as is the case for the
stx2 gene in 933W (7, 45).
|
Effect of osmolarity on phage infection.
To further
characterize Stx2
-II, we examined whether infection of
E. coli K-12 by the phages was affected by changes in
the osmolarity of LB broth, since the infection efficiency of
Stx-converting phages has been shown to be affected by the osmolarity
of the culture medium for growing the indicator E. coli
strain (33). C600 was grown in LB broth containing various
concentrations of NaCl (0 to 0.6 M) or sucrose (0 to 30%), the
bacteria were infected with 5 × 103 PFU of
Stx2-converting phages for 1 h in the media, and the numbers of
infected phages were measured as described in Materials and Methods. As
shown in Fig. 3, the infection efficiency
of Stx2
-I, Stx2
-II, or 933W decreased as the
concentration of NaCl (Fig. 3A) or sucrose (Fig. 3B) increased.
Therefore, the effects of an increase in the osmolarity on the
infection efficiency of Stx2
-I and 933W are similar and are
greater than the effects on the infection efficiency of Stx2
-II.
|
Involvement of outer membrane-associated proteins of
E. coli in Stx2
-II infection.
Stx-converting phages are lambdoid phages (7, 18, 19, 45),
and therefore the involvement of the lamB gene (coding for
the LamB protein) in the infection of C600 by Stx2
-II was checked. The lamB20::Tn5 mutation of GS20 was
introduced by P1 phages into C600, and one of the
lamB20::Tn5 transductants, designated MW47,
was examined for phage sensitivity. Although MW47 (lamB) was
sensitive to Stx2
-I and 933W, its sensitivity to Stx2
-II was greatly diminished (to 0.1% of that to Stx2
-I and 933W)
(Table 4). The reduced efficiency of
Stx2
-II to infect MW47 (lamB) was restored upon
introduction of pMAW301 (the cloned lamB gene in pUC119),
suggesting that the LamB protein is important for Stx2
-II
infection of C600.
|
-I and
933W was greatly affected by changing the osmolarity of the medium used
to grow C600. Since the outer membrane porin proteins such as OmpF and
OmpC are known to be the receptors of phage T2 and T4, respectively
(13, 16, 30) and FadL is known to be the receptor of phage
T2 (31), the effects of defined mutations of
ompC, ompF, or fadL in E. coli on infection of the three converting phages were examined.
Examination of the sensitivity of RAM191
ompC178
zei-198::Tn10 (28) and RK4786
ompF::Tn5 (15) mutants to the
three Stx2-converting phages showed no significant difference among
the phages, suggesting that OmpC and OmpF were not involved in phage infection. In contrast, when a fadL mutation
was introduced into C600(MW72), the bacteria become resistant to
Stx2
-I and 933W and partly resistant to Stx2
-II
(Table 4). The introduction of pMAW302 (a cloned fadL
gene) into MW72 (fadL) restored its sensitivity to
Stx2
-I and 933W, clearly indicating that the FadL protein plays
a crucial role in the infection of E. coli by
Stx2
-I and 933W.
To further investigate the contribution of FadL and LamB proteins in
the infection of E. coli by Stx2-converting phage, a fadL-lamB double mutation was constructed in C600 (MW78
[fadL lamB]) and examined for the extent of
resistance to Stx2
-II. As shown in Table 4, the
sensitivity of MW78 (fadL lamB) to Stx2
-II disappeared, but it was almost completely restored upon
introduction of both plasmid pMAW320 (a cloned fadL
gene in pSU18) and pMAW301 (a cloned lamB gene in pUC119).
Introduction of pMAW320 (a cloned fadL gene in pSU18) alone
into MW78 (fadL lamB) restored the sensitivity to
Stx2
-I and 933W but not Stx2
-II (Table 4), while the
introduction of pMAW301 (a cloned lamB gene in pUC119) into
MW78 (fadL lamB) only partly restored the sensitivity to
Stx2
-II.
Contribution of FadL and LamB protein to Stx2-converting phage
infection.
Table 4 shows that a fadL mutation had a
significant effect on the efficiency of infection of
Stx2-converting phages and that a lamB mutation
affected Stx2
-II infection of E. coli. This was further demonstrated by using a phage neutralization experiment. Outer membrane fractions prepared from each of the strains C600, MW72 (fadL), MW47 (lamB), and MW78 (fadL
lamB) were incubated with Stx2-converting phage at 37°C for 60 min, the phages were plated with C600, and the ineffective phage
numbers were assayed as described in Materials and Methods. The outer
membrane fraction from C600 efficiently inactivated the
infectivity of Stx2
-I, Stx2
-II, and 933W (Fig.
4, column A). However, the outer membrane fraction from strain MW72 (fadL) was unable to inactivate
Stx2
-I and 933W (97 and 98% surviving phages, respectively)
(column B). Under the same conditions, the outer membrane
fraction from MW47 (lamB) could inactivate Stx2
-I and
933W completely (column D). In contrast, the outer membrane
fractions from strain MW72 (fadL) and MW47 (lamB)
could partially inactivate Stx2
-II (59 and 46% surviving
phages, respectively) (column B or D), and the outer membrane fraction
from strain MW78 (fadL lamB) was unable to neutralize the
infectivity of all the three phages (column F). Furthermore, upon
addition of the His-tagged FadL protein to the phage solutions, the infective capacity of Stx2
-I and 933W decreased with
increases of the protein concentration. In fact, at a concentration of
20 µg/ml, the inhibition of the ineffective capacity of
Stx2
-I and 933W to C600 reached the maximum point, at which 75%
of the original phage infectivity (zero) was blocked by the His-tagged
FadL protein (Fig. 5A). In contrast,
inhibition of the infective capacity of Stx2
-II decreased
partially upon addition of the His-tagged FadL or LamB protein (56%
for His-tagged FadL and 47% for LamB) (Fig. 5). These results strongly
suggest that the receptor for Stx2
-I and 933W was the FadL
protein and that for Stx2
-II consisted of the both FadL and LamB
proteins.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Stx1 and Stx2 are the major virulence factors of STEC and are
responsible for the symptoms of bloody diarrhea and HUS. The stx1 and stx2 genes so far reported have been
found as a part of the lambdoid phage genome, thus allowing the toxin
genes to spread easily from one E. coli strain to
another. It is therefore important to investigate the distribution of
Stx-converting phages in STEC strains associated with outbreaks and to
understand their infective properties. In this study, we attempted to
isolate Stx-converting phages from five STEC strains that were
associated with different outbreaks in Japan in 1996 and succeeded in
identifying two different types of Stx2-converting phages, designated
Stx2
-I and Stx2
-II.
Detailed characterization of Stx2
-I and Stx2
-II showed
that the stx2 gene of Stx2
-I and Stx2
-II was
identical to that of 933W, the sole known Stx2-converting phage
(34). Furthermore, it was found that Stx2
-I is
closely related to 933W but not to Stx2
-II and that
Stx2
-II is a novel Stx2-converting phage. Our conclusion was
drawn from the following results. The plaques of Stx2
-II
developed in C600 were significantly smaller than those of
Stx2
-I, for which the morphology of plaques resembled that of
933W. Although the full length of the Stx2
-I genome was similar to that of 933W (7, 34, 45, 49), it was approximately 3 kb
smaller than that of Stx2
-II (Fig. 2). The phage infection immunity displayed by Stx2
-I, Stx2
-II, and 933W revealed
that Stx2
-I and 933W belong to the same immunity group but that
Stx2
-II does not. In support of this view, the effect of changes
in the osmolarity of the medium on the infection of C600 by
Stx2
-I or 933W was different from that on infection by
Stx2
-II (Fig. 5). The differences would result from different
expression of the outer membrane proteins used as the phage receptors
on the host E. coli K-12 in media with different
osmolarities. In fact, the infectivity of Stx2
-I and 933W was
strongly dependent upon the FadL protein expressed on C600, while that
of Stx2
-II was dependent on both LamB and FadL expression (Table
4). The different proteins involved in the phage infection of
E. coli were also confirmed by performing phage
neutralization experiments with outer membrane fractions of the
isogenic E. coli strains with defined lamB,
fadL, or lamB fadL mutations or by using the
purified His6-tagged FadL or LamB protein. These data
clearly indicate that Stx2
-I and Stx2
-II are not
identical to each other but have diverged considerably.
Most double-stranded-DNA-tailed bacteriophages of enteric bacteria have
been assigned to one of several phage groups or so-called quasi-species, where phages of the same group are considered to have a common gene pool. Common to the tailed phages is a highly structured genome composed of a specifically ordered set of
genetic modules (43). The order of the functional genetic
modules is conserved among members of a phage group and sometimes also
between unrelated phage groups. A recent study of 12 lambdoid phage
genomes illustrated that an individual phage genome can be considered to be a particular combination of "alleles" of genetic modules that
are available in the gene pool of that phage group (17). Two
recently published studies documented a surprisingly promiscuous exchange of gene segments across phage group boundaries (12, 42). In this context, it is tempting to speculate that the
different requirements of the outer membrane of E. coli
K-12, as mentioned above, would be reflected by different compositions
of the tail proteins, since the FadL and LamB proteins have been shown
to be the receptors for the T2 and
phages, respectively (29, 40). Taking the above notion into account, we assumed that
recombination of tail fiber gene segments between the Stx2-converting
phages and other phages such as T2 or
phages could have occurred.
Rearrangement of the tail fibers of Stx2-converting phages with those
of some other phages through exchange of part of the tail genes would be beneficial for enhancing the phage host range, resulting in the
emergence of various STEC strains.
In this study, we observed that secretion of Stx2 into the culture
supernatant from C600 lysogenized with Stx2
-I or Stx2
-II was greatly diminished compared with that from the STEC strains Okayama
O-29 and Morioka V526, as determined by ELISA with anti-Stx2 antibody
(Table 2). This is reminiscent of our previous report that secretion of
Stx2 from C600 carrying a cloned stx2 gene was greatly
reduced compared with that from the parental STEC strain (60). Thus, these data suggest that the functions required
for the secretion of Stx2 are not encoded by the phage itself but, rather, may be encoded by the chromosome of STEC. Although the precise
secretion system still remains to be elucidated, it is possible that
the genes required for the secretion of Stx2 protein are located on
some chromosomal region unique to the STEC strains. Indeed, the recent
whole genomic sequencing of some of the STEC strains has indicated that
STEC strains possess at least 1.5 Mb of additional DNA sequence
compared to E. coli K-12 (13a).
Alternatively, the increased secretion of Stx2 from the STEC strains
examined in this study may have resulted from the additional copy of
stx2 genes, as indicated by Schmitt et al. (46),
who showed that STEC strains had two copies of the stx2
gene. Indeed, the STEC strains examined in this study also possess two
copies of the stx2 gene, one in Stx2
-I or
Stx2
-II and the other located somewhere in the chromosome
(data not shown). In any case, we must await the results of further
studies to elucidate the precise secretion system involved in
Stx2 secretion from STEC strains.
STEC strains associated with bloody diarrhea and HUS can be detected by
different methods. The methods that have been used to subtype
E. coli O157:H7 strains include Stx genotype
determination (31), plasmid profile analysis (38,
55), multilocus enzyme electrophoresis (56),
antimicrobial susceptibility (50), bacteriophage typing
(1), random amplified polymorphic DNA fingerprinting (51), and genomic DNA restriction fragment length
polymorphism analysis (39). In addition, pulsed-field
gel electrophoresis has recently been successfully used in the
determination of the molecular epidemiology of STEC strains
(2). We have also developed a detection method for
STEC strains that involves a sensitive bead ELISA and PCR with common
and specific primers for various Stxs (57). The detailed
information on Stx2
-I or Stx2
-II provided by this
study would be useful for epidemiological studies in the future. By applying the facts to the epidemiological classification of STEC strains, we can successfully identify the origin of each outbreak by tracing the route of the food contamination. In this sense,
the development of a monitoring system for the distribution of
Stx-converting phages in members of the
Enterobacteriaceae should be an important step. In this
context, we are currently sequencing the whole genomes of Stx2
-I
and Stx2
-II and seeking phage-specific sequences to develop
diagnostic DNA probes.
| |
ACKNOWLEDGMENTS |
|---|
We thank G. Balakrish Nair for critical reading of the manuscript, Tae Takeda for providing STEC strains, and Hideo Hayashi for valuable discussion.
M. Watarai is the recipient of a Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists. This study was supported by the Organization for Pharmaceutical Safety and Research (OPSR).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Research Institute, International Medical Center of Japan, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162, Japan. Phone: 81-3-5273-6844. Fax: 81-3-3202-7364. E-mail: resedr{at}imcj.go.jp.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ahmed, R., C. Bopp, A. Borczyk, and S. Kasatiya. 1987. Phage-typing scheme for Escherichia coli serotype O157:H7. J. Infect. Dis. 155:806-809[Medline]. |
| 2. | Barrett, T. J., H. Lior, J. H. Green, R. Khaharia, J. G. Wellis, B. P. Bell, K. D. Greene, J. Lewis, and P. M. Griffin. 1994. Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J. Clin. Microbiol. 32:1013-1017. |
| 3. | Bartolomé, B., Y. Jubete, E. Martinez, and F. de la Cruz. 1991. Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives. Gene 102:75-78[Medline]. |
| 4. |
Black, P. N.
1991.
Primary sequence of the Escherichia coli fadL gene encoding an outer membrane protein required for long-chain fatty acid transport.
J. Bacteriol.
173:435-442 |
| 5. | Clement, J. M., and M. Hofnung. 1981. Gene sequence of the lambda receptor, an outer membrane protein of E. coli K12. Cell 27:507-514[Medline]. |
| 6. | Dagert, M., and S. D. Erlich. 1979. Prolonged incubation in calcium chloride improves the competence of Escherichia coli. Gene 6:23-28[Medline]. |
| 7. | Datz, M., C. Janetzki-Mittmann, S. Franke, F. Gunzer, H. Schmidt, and H. Karch. 1996. Analysis of the enterohemorrhagic Escherichia coli O157:H7 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes. Appl. Environ. Microbiol. 62:791-797[Abstract]. |
| 8. | Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Basic methods in molecular biology. Elsevier Science Publishing Co., New York, N.Y. |
| 9. | Gannon, V. P. J., C. Teerling, S. A. Masrei, and C. L. Gyles. 1990. Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. J. Gen. Microbiol. 136:1125-1135[Medline]. |
| 10. |
Griffin, P. M., and R. V. Tauxe.
1991.
The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.
Epidemiol. Rev.
13:60-98 |
| 11. | Gyles, C. L., S. A. DeGrandis, C. MacKenzie, and J. L. Brunton. 1988. Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli. Microb. Pathog. 5:419-426[Medline]. |
| 12. |
Haggard-Ljungquist, E.,
C. Halling, and R. Calendar.
1992.
DNA sequences of the tail fiber genes of bacteriophage P2: evidence for horizontal transfer of tail fiber genes among unrelated bacteriophages.
J. Bacteriol.
174:1462-1477 |
| 13. | Hantke, K. 1978. Major outer membrane proteins of E. coli K12 serve as receptors for the phages T2 (protein 1) and 434 (protein 1). Mol. Gen. Genet. 164:131-135[Medline]. |
| 13a. | Hayashi, H., and H. Shinagawa. Personal communication. |
| 14. | Head, S. C., M. A. Karmali, M. E. Roscoe, M. Petric, N. A. Strockbine, and I. K. Wachsmuth. 1988. Serological differences between verocytotoxin 2 and Shiga-like toxin II. Lancet ii:571. (Letter.) |
| 15. |
Heller, K.,
B. J. Mann, and R. J. Kadner.
1985.
Cloning and expression of the gene for the vitamin B12 receptor protein in the outer membrane of Escherichia coli.
J. Bacteriol.
161:896-903 |
| 16. |
Henning, U., and K. Jahn.
1979.
Two-component nature of bacteriophage T4 receptor activity in Escherichia coli K-12.
J. Bacteriol.
137:664-666 |
| 17. | Highton, P. J., Y. Chang, and R. J. Myers. 1990. Evidence for the exchange of segments between genomes during the evolution of lambdoid bacteriophages. Mol. Microbiol. 4:1329-1340[Medline]. |
| 18. |
Huang, A.,
S. De Grandis,
J. Friesen,
M. Karmali,
M. Petric,
R. Congi, and J. L. Brunton.
1986.
Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19.
J. Bacteriol.
166:375-379 |
| 19. |
Huang, A.,
J. Friesen, and J. L. Brunton.
1987.
Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli.
J. Bacteriol.
169:4308-4312 |
| 20. | Imagawa, M., S. Yoshitake, E. Ishikawa, Y. Niitsu, I. Urushizaki, R. Kanazawa, S. Tachibana, N. Nakazawa, and H. Ogawa. 1982. Development of a highly sensitive sandwich enzyme immunoassay for human ferritin using affinity-purified anti-ferritin labelled with beta-D-galactosidase from Escherichia coli. Clin. Chim. Acta 121:277-289[Medline]. |
| 21. | Ito, H., A. Terai, H. Kurazono, Y. Takeda, and M. Nishibuchi. 1990. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from the Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb. Pathog. 8:47-60[Medline]. |
| 22. | Jackson, M. P., R. J. Neill, A. D. O'Brien, R. K. Holmes, and J. W. Newland. 1987. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44:109-114. |
| 23. | Kurazono, H., C. Sasakawa, M. Yoshikawa, and Y. Takeda. 1987. Cloning of a Vero toxin (VT1, Shiga-like toxin I) gene from a VT1-converting phage isolated from Escherichia coli O157:H7. FEMS Microbiol. Lett. 48:23-26. |
| 24. | Levine, M. M. 1987. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J. Infect. Dis. 155:377-389[Medline]. |
| 25. |
MacLeod, D. L., and C. L. Gyles.
1990.
Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
Infect. Immun.
58:1232-1239 |
| 26. |
Manning, P. A.,
L. Beutin, and M. Achtman.
1980.
Outer membrane of Escherichia coli: properties of the F sex factor traT protein which is involved in surface exculusion.
J. Bacteriol.
142:285-294 |
| 27. | Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 28. |
Misra, R., and S. A. Benson.
1988.
Isolation and characterization of OmpC porin mutants with altered pore properties.
J. Bacteriol.
170:528-533 |
| 29. |
Morona, R., and U. Henning.
1986.
New locus (ttr) in Escherichia coli K-12 affecting sensitivity to bacteriophage T2 and growth on oleate as the sole carbon source.
J. Bacteriol.
168:534-540 |
| 30. |
Mutoh, N.,
H. Furukawa, and S. Mizushima.
1978.
Role of lipopolysaccharide and outer membrane protein of Escherichia coli K-12 in the receptor activity for bacteriophage T4.
J. Bacteriol.
136:693-699 |
| 31. |
Newland, J. W., and R. J. Neill.
1988.
DNA probes for Shiga-like toxins I and II and for toxin-converting phages.
J. Clin. Microbiol.
26:1292-1297 |
| 32. | Noda, M., T. Yutsudo, N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2:339-349[Medline]. |
| 33. |
O'Brien, A. D.,
J. W. Newland,
S. F. Miller,
R. K. Holmes,
H. W. Smith, and S. B. Formal.
1984.
Shiga-like toxin-cinverting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.
Science
226:694-696 |
| 34. | O'Brien, A. D., L. R. M. Marques, C. F. Kerry, J. W. Newland, and R. K. Holmes. 1989. Shiga-like toxin converting phage of enterohemorrhagic Escherichia coli strain 933. Microb. Pathog. 6:381-390[Medline]. |
| 35. | O'Brien, A. D., V. L. Tesh, A. Donohue-Rolfe, M. P. Jackson, S. Olsnes, K. Sandvig, A. A. Lindberg, and G. T. Keusch. 1992. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180:65-94[Medline]. |
| 36. | Oku, Y., Y. Uesaka, T. Hirayama, and Y. Takeda. 1988. Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. Microbiol. Immunol. 32:807-816[Medline]. |
| 37. |
Oliver, D. B.
1985.
Identification of five new essential genes involved in the synthesis of a secreted protein in Escherichia coli.
J. Bacteriol.
161:285-291 |
| 38. | Ostroff, S. M., P. I. Tarr, M. A. Neill, J. H. Lewins, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infection. J. Infect. Dis. 160:994-998[Medline]. |
| 39. | Paros, M., P. I. Tarr, H. Kim, T. E. Besser, and D. D. Hancock. 1993. A comparison of human and bovine Escherichia coli O157:H7 isolates by toxin genotype, plasmid profile, and bacteriophage lambda-restriction fragment length polymorphism profile. J. Infect. Dis. 168:1300-1303[Medline]. |
| 40. |
Randall-Hazelbauer, L., and M. Schwartz.
1973.
Isolation of the bacteriophage lambda receptor from Escherichia coli.
J. Bacteriol.
116:1436-1446 |
| 41. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 42. |
Sandmeier, H.,
S. Iida, and W. Arber.
1992.
DNA inversion regions Min of plasmid p15B and Cin of bacteriophage P1: evolution of bacteriophage tail fiber genes.
J. Bacteriol.
174:3936-3944 |
| 43. | Sandmeier, H. 1994. Acquisition and rearrangement of sequence motifs in the evolution of bacteriophage tail fibres. Mol. Microbiol. 12:343-350[Medline]. |
| 44. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 45. | Schmidt, H., J. Scheef, C. Janetzki-Mittmann, M. Datz, and H. Karch. 1997. An ileX tRNA gene is located close to the Shiga toxin II operon in enterohemorrhagic Escherichia coli O157 and non-O157 strains. FEMS Microbiol. Lett. 149:39-44[Medline]. |
| 46. |
Schmitt, C. K.,
M. L. McKee, and A. D. O'Brien.
1991.
Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H strain E32511.
Infect. Immun.
59:1065-1073 |
| 47. | Scotland, S. M., H. R. Smith, and B. Rowe. 1985. Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet ii:885-886. |
| 48. | Smith, H. W., P. Green, and Z. Parsell. 1983. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens, and pigs. J. Gen. Microbiol. 129:3121-3137[Medline]. |
| 49. |
Strockbine, N. A.,
L. R. M. Marques,
J. W. Newland,
H. W. Smith,
R. K. Holmes, and A. D. O'Brien.
1986.
Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.
Infect. Immun.
53:135-140 |
| 50. | Swerdlow, D. L., B. A. Woodruff, R. C. Brady, P. M. Griffin, S. Tippen, H. D. Donnell, E. Geldreich, B. J. Payne, A. Meyer, J. G. Wells, K. D. Greene, M. Bright, N. H. Bean, and P. A. Blake. 1992. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann. Intern. Med. 117:812-818. |
| 51. | Wang, G., T. S. Whittam, C. M. Berg, and D. E. Berg. 1993. RAPD (arbitrary primer) PCR is more sensitive than multilocus enzyme electrophoresis for distinguishing related bacterial strains. Nucleic Acids Res. 2157:5930-5933. |
| 52. | Watanabe, H., A. Wada, and Y. Inagaki. 1996. Outbreaks of enterohaemorrhagic Escherichia coli O157:H7 infection by two different genotype strains in Japan, 1996. Lancet 348:831-832[Medline]. |
| 53. | Watarai, M., T. Tobe, M. Yoshikawa, and C. Sasakawa. 1995. Contact of Shigella with host cells triggers release of Ipa invasins and is an essential function of invasiveness. EMBO J. 14:2461-2470[Medline]. |
| 54. |
Weinstein, D. L.,
M. P. Jackson,
J. E. Samuel,
R. K. Holmes, and A. D. O'Brien.
1988.
Cloning and sequencing of a Shiga-like toxin II variant from an Escherichia coli strain responsible for edema disease of swine.
J. Bacteriol.
170:4223-4230 |
| 55. |
Wells, J. G.,
B. R. Davis,
I. K. Wachsmuth,
L. W. Riley,
R. S. Remis,
R. Sokolow, and G. K. Morris.
1983.
Laboratory investigation of hemorrhagic colitis associated with a rare Escherichia coli serotype.
J. Clin. Microbiol.
18:512-520 |
| 56. | Whittam, T. S., I. K. Wachsmuth, and R. A. Wilson. 1988. Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J. Infect. Dis. 157:1124-1133[Medline]. |
| 57. | Yamasaki, S., S. Lin, H. Shirai, A. Terai, Y. Oku, H. Ito, M. Ohmura, T. Karasawa, T. Tsukamoto, H. Kurazono, and Y. Takeda. 1996. Typing of verotoxins by DNA hybridization with poly- and oligonucleotide probes, a bead-enzyme-linked immunosorbent assay, and polymerase chain reaction. Microbiol. Immunol. 40:345-352[Medline]. |
| 58. | Yutsudo, T., N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:21-30[Medline]. |
| 59. | Yutsudo, T., H. Kurazono, C. Sasakawa, M. Yoshikawa, and Y. Takeda. 1987. Cloning of a Vero toxin (VT2) gene from a VT2-converting phage isolated from Escherichia coli O157:H7. FEMS Microbiol. Lett. 48:273-276. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||